Related references
Note: Only part of the references are listed.HCV-related advanced fibrosis/cirrhosis:: randomized controlled trial of pegylated interferon α-2a and ribavirin
Beat Helbling et al.
JOURNAL OF VIRAL HEPATITIS (2006)
Standard interferon-alpha in combination with ribavirin for hepatitis C patients with advanced liver disease and thrombocytopenia
Harald Hofer et al.
WIENER KLINISCHE WOCHENSCHRIFT (2006)
AMG 531, a thrombopoiesis-stimulating protein, for chronic ITP
James B. Bussel et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Results of combination treatment with pegylated interferon and ribavirin in cirrhotic patients with hepatitis C infection
Barbara Horoldt et al.
LIVER INTERNATIONAL (2006)
Late onset autoimmune thrombocytopenia associated with pegylated interferon-α-2b plus ribavirin treatment for chronic hepatitis C
IS Elefsiniotis et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2006)
Differential effects of a novel IFN-ζ/limitin and IFN-α on signals for Daxx induction and Crk phosphorylation that couple with growth control of megakaryocytes
N Ishida et al.
EXPERIMENTAL HEMATOLOGY (2005)
Peginterferon alfa-2a and ribavirin in patients with chronic hepatitis C who have failed prior treatment
ML Shiffman et al.
GASTROENTEROLOGY (2004)
Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection.
MW Fried et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Development of pancytopenia with neutralizing antibodies to thrombopoietin after multicycle chemotherapy supported by megakaryocyte growth and development factor
RL Basser et al.
BLOOD (2002)
Thrombocytopenia caused by the development of antibodies to thrombopoietin
JZ Li et al.
BLOOD (2001)
Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial
MP Manns et al.
LANCET (2001)
An essential role for Daxx in the inhibition of B lymphopoiesis by type I interferons
R Gongora et al.
IMMUNITY (2001)
Peginterferon alfa-2a in patients with chronic hepatitis C and cirrhosis
EJ Heathcote et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
Rapid onset of hematotoxic effects after interferon alpha in hepatitis C
H Dormann et al.
JOURNAL OF HEPATOLOGY (2000)
Perinatal synthetic lethality and hematopoietic defects in compound mafG:mafK mutant mice
K Onodera et al.
EMBO JOURNAL (2000)